Although the epidemiologic evidence that adequate vitamin D nutrition protects against non-melanoma skin cancer (NMSC) is limited, recent evidence that the vitamin D receptor (VDR) is protective is compelling. The role of vitamin D signaling in limiting the proliferation while promoting the differentiation of keratinocytes, the major cell in the epidermis from which NMSC are derived, is well known. However, recent findings that mice lacking the VDR are predisposed to skin cancer has brought to the fore the question of how the VDR is protective. In this review we will look first at the role of vitamin D signaling in regulating the proliferation and differentiation of keratinocytes. We will examine two pathways, β-catenin (CTNNB) and hedgehog...
ΔNp63α, a proto-oncogene, is up-regulated in non-melanoma skin cancers and directly regulates the ex...
We have investigated how Wnt and vitamin D receptor signals regulate epidermal differentiation. Many...
The vitamin D receptor (VDR) ligand, 1,25 dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), reduces prolifera...
Although the epidemiologic evidence that adequate vitamin D nutrition protects against non-melanoma ...
Vitamin D sufficiency is associated with protection against malignancy in a number of tissues clinic...
Epidemiologic evidence supporting a major chemopreventive role for vitamin D in various malignancies...
Cutaneous malignancies including melanomas and non melanoma skin cancers (NMSC) are the most common ...
1,25 dihydroxyvitamin D (1,25(OH)2D), the active metabolite of vitamin D, and calcium regulate epide...
Although the epidemiologic evidence that adequate vitamin D nutrition protects against non-melanoma ...
Sunlight, vitamin D and skin cancer form a controversial brew. While too much sunlight exposure caus...
Ultra violet (UV) irradiation, in particular UVB, is the single most important carcinogen for skin t...
Non-melanoma skin cancers (NMSC) are the most common type of cancer, occurring at a rate of over 1 m...
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) is the biologically active ligand for the vitamin D receptor ...
DNp63a, a proto-oncogene, is up-regulated in non-melanoma skin cancers and directly regulates the ex...
<div><p>ΔNp63α, a proto-oncogene, is up-regulated in non-melanoma skin cancers and directly regulate...
ΔNp63α, a proto-oncogene, is up-regulated in non-melanoma skin cancers and directly regulates the ex...
We have investigated how Wnt and vitamin D receptor signals regulate epidermal differentiation. Many...
The vitamin D receptor (VDR) ligand, 1,25 dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), reduces prolifera...
Although the epidemiologic evidence that adequate vitamin D nutrition protects against non-melanoma ...
Vitamin D sufficiency is associated with protection against malignancy in a number of tissues clinic...
Epidemiologic evidence supporting a major chemopreventive role for vitamin D in various malignancies...
Cutaneous malignancies including melanomas and non melanoma skin cancers (NMSC) are the most common ...
1,25 dihydroxyvitamin D (1,25(OH)2D), the active metabolite of vitamin D, and calcium regulate epide...
Although the epidemiologic evidence that adequate vitamin D nutrition protects against non-melanoma ...
Sunlight, vitamin D and skin cancer form a controversial brew. While too much sunlight exposure caus...
Ultra violet (UV) irradiation, in particular UVB, is the single most important carcinogen for skin t...
Non-melanoma skin cancers (NMSC) are the most common type of cancer, occurring at a rate of over 1 m...
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) is the biologically active ligand for the vitamin D receptor ...
DNp63a, a proto-oncogene, is up-regulated in non-melanoma skin cancers and directly regulates the ex...
<div><p>ΔNp63α, a proto-oncogene, is up-regulated in non-melanoma skin cancers and directly regulate...
ΔNp63α, a proto-oncogene, is up-regulated in non-melanoma skin cancers and directly regulates the ex...
We have investigated how Wnt and vitamin D receptor signals regulate epidermal differentiation. Many...
The vitamin D receptor (VDR) ligand, 1,25 dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), reduces prolifera...